FDA Clearance Tracker · K190416
Dome Electrode
Last checked: Nov 20, 2026Latest source record: Apr 4, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Apr 4, 2019
Substantially Equivalent
Time to decision
42 days
Received Feb 21, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Abbreviated
Device class
Class II
The decision
- FDA number
- K190416
- Device name
- Dome Electrode
- Applicant
- Coapt, LLC
- Applicant location
- Chicago, IL
- Received
- Feb 21, 2019
- Decided
- Apr 4, 2019
- Decision
- Substantially Equivalent
- Submission type
- Abbreviated
Device type
- Device type
- Electrode, Cutaneous (GXY)
- Device class
- Class II
- Regulation
- 21 CFR 882.1320
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXY. The earliest in FDA's data is K760312, decided Aug 4, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K190416
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Coapt, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K191083 · Decided May 24, 2019 · 30 days after receipt
Device type: Electrode, Cutaneous (GXY) · Neurology & Neurosurgery
- Complete Control System510(k)
K162891 · Decided Apr 14, 2017 · 179 days after receipt
Device type: Electrode, Cutaneous (GXY) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.